TRIM66 and lung cancer: The role of TRIM66 in promoting lung cancer progression was later confirmed by Chen et al. [246], who demonstrated that TRIM66 upregulation modulates the level of MMP9 that subsequently induces the TGF-β/SMAD signaling pathway, enhancing tumor aggressiveness.